CRESCENT BIOPHARMA, INC. Preferred Stock, Shares Outstanding
CRESCENT BIOPHARMA, INC. (CBIO) had Preferred Stock, Shares Outstanding of 2.89 thousand shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-07-30
- 2026-06-30: Preferred Stock, Shares Outstanding 2.89K shares.
- 2026-03-31: Preferred Stock, Shares Outstanding 2.89K shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 2.89K shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 2.89K shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 2.89K shares 10-Q · filed 2026-04-29 |
| 2025-12-31 | 2.89K shares 10-Q · filed 2026-07-30 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares 10-Q · filed 2025-05-14 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-02-13 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-02 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-03 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-03 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-04-28 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-03 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-06 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-07-31 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-01 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-02 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-02-28 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-02 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-03 |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-03 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-08 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-06 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-04 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-04 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-01 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-05 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-10-31 |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-07-31 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |